Plasma Cell precursor and Other Disorders
Open-Label Phase 1b Study to Evaluate the Safety and Efficacy of ABBV-383 Monotherapy in Patients With Relapsed or Refractory Light Chain Amyloidosis
Shaji K. Kumar, MD
Professor of Medicine/Consultant
Mayo Clinic, Rochester, MN, US
Rochester, Minnesota, United States